MDisrupt is a Medical Diligence company for the healthtech industry, helping investors and entrepreneurs get impactful health products to market faster and more responsibly.
No articles found.
Cann American Corp. acts as a Holding Company for the sake of developing assets wi...
Cann American Corp. acts as a Holding Company f...
 
                  Tetra Tech is a leading provider of high-end consulting and engineering services f...
Tetra Tech is a leading provider of high-end co...
 
                  ISG (Information Services Group) (Nasdaq: III) is a leading global technology rese...
ISG (Information Services Group) (Nasdaq: III) ...
 
                  EyeGate is developing and commercializing products for treating diseases and disor...
EyeGate is developing and commercializing produ...
 
                  Personalis, Inc. is a growing cancer genomics company transforming the development...
Personalis, Inc. is a growing cancer genomics c...
 
                  Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthro...
Eyenovia is a late-stage ophthalmic biopharmace...
 
                  Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fiel...
Astellas Pharma Inc. is a pharmaceutical compan...
 
                  STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, de...
STAAR, which has been dedicated solely to ophth...
 
                  Natural Alternatives International, Inc. (NAI) is the industry-leading formulator ...
Natural Alternatives International, Inc. (NAI) ...
 
                  Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund th...
Firsthand Technology Value Fund, Inc. is a publ...
Join the National Investor Network and get the latest information with your interests in mind.